Guy Nichols named chief medical officer of MPLN

Guy Nichols, MD, PhD, board certified in hematopathology, cytopathology and anatomic and clinical pathology, recently joined Molecular Pathology Laboratory Network, Inc. (MPLN) as chief medical officer (CMO).

As CMO, Dr. Nichols will offer professional consultative services and build peer to peer relationships with our clients. He will also support and guide clients on appropriate testing by integrating evidence-based laboratory medicine with modern pathology services.

In addition to his role as CMO, Dr. Nichols will serve as the medical director of our laboratory in Richmond, VA. With more than 15 years experience in university and community pathology practice, Dr. Nichols brings a wealth of experience and knowledge, which will enhance the high-quality, personalized services we provide.

Dr. Nichols received his Bachelor of Science degree in biochemistry from the University of Maine, where he was valedictorian in 1981. Thereafter, he earned his medical and doctoral degrees from the University of Virginia, School of Medicine. He went on to complete his residency in anatomic and clinical pathology at the University of Virginia Health Sciences Center, where he was later appointed assistant professor of pathology and served as medical director of the immunohistochemistry laboratory and as residency program director.

Dr. Nichols is a well respected industry leader and a Diplomat of the American Board of Pathology in Anatomic and Clinical Pathology, Cytopathology and Hematology. He is also a past president of the Virginia Society for Pathology. In 2004 and 2006, Dr. Nichols was named “best pathologist” by his peers in the Richmond area.

For more information about MPLN’s advanced technologies and personalized services, call 800-932-2943 or visit

MPLN is a privately held molecular diagnostic laboratory founded in 1989 and headquartered in Maryville, Tenn. A leader in laboratory medicine, MPLN offers a comprehensive selection of molecular diagnostics and cytogenetic testing that targets oncology, women’s health, prenatal care, medical genetics and pharmacogenetics and infectious disease.

The laboratory also has extensive expertise in chromosome analysis, flow cytometry, fluorescence in situ hybridization (FISH), real-time and quantitative polymerase chain reaction technologies, immunohistochemistry and gene sequencing.

MPLN is certified by the Clinical Laboratory Improvement Amendments (CLIA), accredited by the College of American Pathologists (CAP), and licensed by the states of Tennessee, Florida, New York and Maryland.

© 2010 All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

  • Discuss
  • Print

Comments » 0

Be the first to post a comment!